• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[多巴酚丁胺和米力农用于重度心力衰竭患者的血流动力学:个体内比较]

[Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].

作者信息

Mager G, Klocke R K, Volkmann A, Kux A, Höpp H W, Hilger H H

机构信息

Klinik III für Innere Medizin, Universität zu Köln.

出版信息

Z Kardiol. 1991 Feb;80(2):149-57.

PMID:2058247
Abstract

Hemodynamics during 24-h dobutamine (dob) and subsequent 24-h milrinone (mil) infusion were studied in 20 patients (pts) with severe heart failure (NYHA III: 4 pts, NYHA IV: 16 pts). Three of 20 patients showed a heart-rate increase to 140 bpm and more during dob; five patients were non-responders to dob. Heart rate rose (p less than or equal to 0.001) during dob from 88.8 to 105.6 bpm (+1 hr) and then decreased to 93.0 bpm after 24 h; stroke volume index increased (p less than or equal to 0.001) from 19.3 to 28.9 ml.m-2 (+49.6%) after 1 h and then decreased to 25.2 ml.m-2 after 12 h as did heart rate. During mil heart rate did not change; stroke volume index increased from 18.8 to 31.2 (+66.0%, p less than or equal to 0.001) after 1 h and showed no development of tolerance during the rest of the infusion period. PCWP decreased (p less than or equal to 0.001) during mil from 26.5 to 16.2 mm Hg after 30 min, tending upward again to 20.1 mm Hg after 24 h; during dob the decrease (p less than or equal to 0.01) of PCWP from 27.8 to 19.0 mm Hg after 6 h was delayed, also tending upward during the rest of the infusion period to 22.7 mm Hg after 24 h. There was no sustained decrease of PVR during dob, but after the start of mil infusion PVR decreased (p less than or equal to 0.001) from 312.7 to 172.1 dynes/s/cm-5 (+15 min), remaining on this level during the rest of mil infusion.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对20例重度心力衰竭患者(纽约心脏协会III级:4例,纽约心脏协会IV级:16例)进行了研究,观察了24小时多巴酚丁胺(dob)输注及随后24小时米力农(mil)输注期间的血流动力学变化。20例患者中有3例在多巴酚丁胺输注期间心率增加至140次/分钟及以上;5例患者对多巴酚丁胺无反应。多巴酚丁胺输注期间心率从88.8次/分钟升至105.6次/分钟(+1小时)(p≤0.001),24小时后降至93.0次/分钟;每搏量指数在1小时后从19.3增加至28.9ml·m-2(+49.6%)(p≤0.001),12小时后降至25.2ml·m-2,心率变化情况与之相同。米力农输注期间心率未改变;每搏量指数在1小时后从18.8增加至31.2(+66.0%,p≤0.001),在输注期其余时间未出现耐受性发展。米力农输注30分钟后肺毛细血管楔压(PCWP)从26.5mmHg降至16.2mmHg(p≤0.001),24小时后又升至20.1mmHg;多巴酚丁胺输注6小时后PCWP从27.8mmHg降至19.0mmHg(p≤0.01)出现延迟,输注期其余时间也上升,24小时后升至22.7mmHg。多巴酚丁胺输注期间肺血管阻力(PVR)无持续下降,但米力农输注开始后PVR在15分钟内从312.7降至172.1达因/秒/厘米-5(p≤0.001),在米力农输注其余时间维持在该水平。(摘要截短至250字)

相似文献

1
[Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].[多巴酚丁胺和米力农用于重度心力衰竭患者的血流动力学:个体内比较]
Z Kardiol. 1991 Feb;80(2):149-57.
2
[The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure].[24小时米力农输注血流动力学变化对重症心力衰竭患者交感神经活性及肾素-血管紧张素-醛固酮系统的影响]
Z Kardiol. 1991 Apr;80(4):272-8.
3
[Additive effects of milrinone and dobutamine in severe heart failure].米力农与多巴酚丁胺对重症心力衰竭的相加作用
Z Kardiol. 1992 May;81(5):266-71.
4
A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.一项针对重度心力衰竭患者进行米力农48小时静脉输注的加拿大多中心研究。
Can J Cardiol. 1991 Jan-Feb;7(1):5-10.
5
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.米力农和多巴酚丁胺用于严重心力衰竭:不同的血流动力学效应及个体患者反应性
Circulation. 1986 Mar;73(3 Pt 2):III175-83.
6
[Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].多巴胺/米力农与多巴胺/多巴酚丁胺治疗心源性休克的对比研究
Z Kardiol. 1996 Nov;85(11):839-46.
7
[The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].[氨力农和依诺昔酮在重症心力衰竭患者中的血流动力学特征]
Z Kardiol. 1991;80 Suppl 4:63-7.
8
Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.磷酸二酯酶III抑制或肾上腺素能受体刺激:米力农作为治疗严重心力衰竭时替代多巴酚丁胺的药物。
Am Heart J. 1991 Jun;121(6 Pt 2):1974-83. doi: 10.1016/0002-8703(91)90834-5.
9
[Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].[依诺昔酮与多巴胺联合治疗中的神经体液和血流动力学效应]
Z Kardiol. 1994;83 Suppl 2:37-48.
10
Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.米力农、多巴酚丁胺和硝普钠:对重度充血性心力衰竭患者血流动力学和心肌能量代谢的比较影响。
Circulation. 1986 Mar;73(3 Pt 2):III168-74.

引用本文的文献

1
Current status of phosphodiesterase inhibitors in the treatment of congestive heart failure.磷酸二酯酶抑制剂在治疗充血性心力衰竭中的现状
Drugs. 1992 Dec;44(6):928-45. doi: 10.2165/00003495-199244060-00003.